Human Genome Epidemiology Literature Finder
|
Records 1 - 22 (of 22 Records) |
| Query Trace: Carcinoma and KDM5C[original query] |
|---|
| Exome sequencing identifies frequent mutation of the SWI/SNF complex gene PBRM1 in renal carcinoma. Nature 2011 1 469 (7331): 539-42. Varela Ignacio, Tarpey Patrick, Raine Keiran, Huang Dachuan, Ong Choon Kiat, Stephens Philip, Davies Helen, Jones David, Lin Meng-Lay, Teague Jon, Bignell Graham, Butler Adam, Cho Juok, Dalgliesh Gillian L, Galappaththige Danushka, Greenman Chris, Hardy Claire, Jia Mingming, Latimer Calli, Lau King Wai, Marshall John, McLaren Stuart, Menzies Andrew, Mudie Laura, Stebbings Lucy, Largaespada David A, Wessels L F A, Richard Stephane, Kahnoski Richard J, Anema John, Tuveson David A, Perez-Mancera Pedro A, Mustonen Ville, Fischer Andrej, Adams David J, Rust Alistair, Chan-on Waraporn, Subimerb Chutima, Dykema Karl, Furge Kyle, Campbell Peter J, Teh Bin Tean, Stratton Michael R, Futreal P Andr |
| Clinical and pathologic impact of select chromatin-modulating tumor suppressors in clear cell renal cell carcinoma. European urology 2012 Sep . Hakimi AA, Chen YB, Wren J, Gonen M, Abdel-Wahab O, Heguy A, Liu H, Takeda S, Tickoo SK, Reuter VE, Voss MH, Motzer RJ, Coleman JA, Cheng EH, Russo P, Hsieh JJ |
| Radiogenomics of clear cell renal cell carcinoma: associations between CT imaging features and mutations. Radiology 2014 Feb 270 (2): 464-71. Karlo Christoph A, Di Paolo Pier Luigi, Chaim Joshua, Hakimi A Ari, Ostrovnaya Irina, Russo Paul, Hricak Hedvig, Motzer Robert, Hsieh James J, Akin Og |
| Radiogenomics of clear cell renal cell carcinoma: preliminary findings of The Cancer Genome Atlas-Renal Cell Carcinoma (TCGA-RCC) Imaging Research Group. Abdominal imaging 2015 Aug 40 (6): 1684-92. Shinagare Atul B, Vikram Raghu, Jaffe Carl, Akin Oguz, Kirby Justin, Huang Erich, Freymann John, Sainani Nisha I, Sadow Cheryl A, Bathala Tharakeswara K, Rubin Daniel L, Oto Aytekin, Heller Matthew T, Surabhi Venkateswar R, Katabathina Venkat, Silverman Stuart |
| Gender Specific Mutation Incidence and Survival Associations in Clear Cell Renal Cell Carcinoma (CCRCC). PloS one 2015 10 (10): e0140257. Ricketts Christopher J, Linehan W Marst |
| Genomic Biomarkers of a Randomized Trial Comparing First-line Everolimus and Sunitinib in Patients with Metastatic Renal Cell Carcinoma. European urology 2016 Oct . Hsieh James J, Chen David, Wang Patricia I, Marker Mahtab, Redzematovic Almedina, Chen Ying-Bei, Selcuklu S Duygu, Weinhold Nils, Bouvier Nancy, Huberman Kety H, Bhanot Umesh, Chevinsky Michael S, Patel Parul, Pinciroli Patrizia, Won Helen H, You Daoqi, Viale Agnes, Lee William, Hakimi A Ari, Berger Michael F, Socci Nicholas D, Cheng Emily H, Knox Jennifer, Voss Martin H, Voi Maurizio, Motzer Robert |
| Genomic alterations as predictors of survival among patients within a combined cohort with clear cell renal cell carcinoma undergoing cytoreductive nephrectomy. Urologic oncology 2017 Apr . Tennenbaum Daniel M, Manley Brandon J, Zabor Emily, Becerra Maria F, Carlo Maria I, Casuscelli Jozefina, Redzematovic Almedina, Khan Nabeela, Arcila Maria E, Voss Martin H, Feldman Darren R, Motzer Robert J, Benfante Nicole E, Coleman Jonathan A, Russo Paul, Hsieh James J, Hakimi Abraham A |
| Genetic characterization of Polish ccRCC patients: somatic mutation analysis of PBRM1, BAP1 and KDMC5, genomic SNP array analysis in tumor biopsy and preliminary results of chromosome aberrations analysis in plasma cell free DNA. Oncotarget 2017 Feb . Kluzek Katarzyna, Srebniak Malgorzata I, Majer Weronika, Ida Agnieszka, Milecki Tomasz, Huminska Kinga, van der Helm Robert M, Silesian Adrian, Wrzesinski Tomasz M, Wojciechowicz Jacek, Beverloo Berna H, Kwias Zbigniew, Bluyssen Hans A R, Wesoly Joan |
| Characterizing recurrent and lethal small renal masses in clear cell renal cell carcinoma using recurrent somatic mutations. Urologic oncology 2017 11 37 (1): 12-17. Manley Brandon J, Reznik Ed, Ghanaat Mazyar, Kashan Mahyar, Becerra Maria F, Casuscelli Jozefina, Tennenbaum Daniel, Redzematovic Almedina, Carlo Maria I, Sato Yusuke, Arcila Maria, Voss Martin H, Feldman Darren R, Motzer Robert J, Russo Paul, Coleman Jonathan, Hsieh James J, Hakimi Ari |
| Comprehensive Genetic Analysis of Follicular Thyroid Carcinoma Predicts Prognosis Independent of Histology. The Journal of clinical endocrinology and metabolism 2018 07 103 (7): 2640-2650. Nicolson Norman G, Murtha Timothy D, Dong Weilai, Paulsson Johan O, Choi Jungmin, Barbieri Andrea L, Brown Taylor C, Kunstman John W, Larsson Catharina, Prasad Manju L, Korah Reju, Lifton Richard P, Juhlin C Christofer, Carling Tobi |
| Comprehensive Genomic Profiling of Metastatic Tumors in a Phase 2 Biomarker Study of Everolimus in Advanced Renal Cell Carcinoma. Clinical genitourinary cancer 2018 5 16 (5): 341-348. Gao Xin, Jegede Opeyemi, Gray Connor, Catalano Paul J, Novak Jesse, Kwiatkowski David J, McKay Rana R, George Daniel J, Choueiri Toni K, McDermott David F, Signoretti Sabina, Bhatt Rupal |
| Genomically annotated risk model for advanced renal-cell carcinoma: a retrospective cohort study. The Lancet. Oncology 2018 12 19 (12): 1688-1698. Voss Martin H, Reising Albert, Cheng Yuan, Patel Parul, Marker Mahtab, Kuo Fengshen, Chan Timothy A, Choueiri Toni K, Hsieh James J, Hakimi A Ari, Motzer Robert |
| Mutations and Response to Rapalogs in Patients with Metastatic Renal Cell Carcinoma. Molecular cancer therapeutics 2019 Oct . Nassar Amin H, Hamieh Lana, Gray Kathryn P, Thorner Aaron R, Fay Andre P, Lasseter Kathryn D, Abou Alaiwi Sarah, Nuzzo Pier Vitale, Flippot Ronan, Krajewski Katherine M, Signoretti Sabina, Choueiri Toni K, Kwiatkowski David |
| Correlates of clinical benefit from immunotherapy and targeted therapy in metastatic renal cell carcinoma: comprehensive genomic and transcriptomic analysis. Journal for immunotherapy of cancer 2020 7 8 (2): . Dizman Nazli, Lyou Yung, Salgia Nicholas, Bergerot Paulo Gustavo, Hsu JoAnn, Enriquez Daniel, Izatt Tyler, Trent Jeffrey M, Byron Sara, Pal Suman |
| Molecular Subsets in Renal Cancer Determine Outcome to Checkpoint and Angiogenesis Blockade. Cancer cell 2020 11 38 (6): 803-817.e4. Motzer Robert J, Banchereau Romain, Hamidi Habib, Powles Thomas, McDermott David, Atkins Michael B, Escudier Bernard, Liu Li-Fen, Leng Ning, Abbas Alexander R, Fan Jinzhen, Koeppen Hartmut, Lin Jennifer, Carroll Susheela, Hashimoto Kenji, Mariathasan Sanjeev, Green Marjorie, Tayama Darren, Hegde Priti S, Schiff Christina, Huseni Mahrukh A, Rini Bri |
| Somatic mutations as preoperative predictors of metastases in patients with localized clear cell renal cell carcinoma - An exploratory analysis. Urologic oncology 2021 9 39 (11): 791.e17-791.e24. Mano Roy, Duzgol Cihan, Ganat Maz, Goldman Debra A, Blum Kyle A, Silagy Andrew W, Walasek Aleksandra, Sanchez Alejandro, DiNatale Renzo G, Marcon Julian, Kashan Mahyar, Becerra Maria F, Benfante Nicole E, Coleman Jonathan A, Kattan Michael W, Russo Paul, Akin Oguz, Ostrovnaya Irina, Hakimi A A |
| Relationship between visceral adipose tissue and genetic mutations (VHL and KDM5C) in clear cell renal cell carcinoma. La Radiologia medica 2021 Jan . Greco Federico, Mallio Carlo Augus |
| Identification of Survival-Specific Genes in Clear Cell Renal Cell Carcinoma Using a Customized Next-Generation Sequencing Gene Panel. Journal of personalized medicine 2022 Jan 12 (1): . Hwang Jia, Kim Heeeun, Han Jinseon, Lee Jieun, Hong Sunghoo, Kim Saewoong, Yoon Sungjoo Kim, Choi Keonwoo, Yang Jihoon, Park Unsang, Kim Kwangjoong, Yim Kwangil, Kim Yuil, Choi Yeongj |
| Sex-specific survival gene mutations are discovered as clinical predictors of clear cell renal cell carcinoma. Scientific reports 2024 7 14 (1): 15800. Jia Hwang, Hye Eun Lee, Jin Seon Han, Moon Hyung Choi, Sung Hoo Hong, Sae Woong Kim, Ji Hoon Yang, Unsang Park, Eun Sun Jung, Yeong Jin Ch |
| Mutational profile of primary clear cell renal cell carcinoma predicts recurrence and potential candidacy for adjuvant immune checkpoint inhibition. F1000Research 2024 6 12 918. Panagiotis J Vlachostergios, Maria Papathanassiou, Maria Anagnostou, Eleni Thodou, Ioannis Tamposis, Lampros Mitrakas, Ioannis Zachos, George K Koukoulis, Maria Samara, Vassilios Tzortz |
| Biomarker analyses from the phase 3 randomized CLEAR trial: Lenvatinib plus pembrolizumab versus sunitinib in advanced renal cell carcinoma. Annals of oncology : official journal of the European Society for Medical Oncology 2024 12 . R J Motzer, C Porta, M Eto, T E Hutson, S Y Rha, J R Merchan, E Winquist, H Gurney, V Grünwald, S George, J Markensohn, J E Burgents, R Cristescu, P Sachdev, Y Narita, J Huang, Z Zhao, C E Okpara, Y Minoshima, T K Chouei |
| Chromosome 3p gene alterations as biomarkers for immunocombinations in metastatic renal cell carcinoma: A hypothesis-generating analysis. Pathology, research and practice 2024 1 254 155142. Matteo Rosellini, Veronica Mollica, Andrea Marchetti, Sara Coluccelli, Francesca Giunchi, Elisa Tassinari, Costantino Ricci, Michelangelo Fiorentino, Giovanni Tallini, Dario De Biase, Francesco Massa |
- Page last reviewed:Feb 1, 2024
- Content source: